The Middle EAST Epithelioma Treatment Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors including an increasing prevalence of epithelioma cases, advancements in treatment technologies, and a growing awareness of skin cancer among the population. The rising incidence...